Viewing Study NCT06751966


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2025-12-26 @ 9:32 AM
Study NCT ID: NCT06751966
Status: RECRUITING
Last Update Posted: 2024-12-30
First Post: 2024-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
Sponsor: The First Affiliated Hospital of Nanchang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module